MedPath

Ethacrynic Sodium

{'content': {'@styleCode': 'bold'}}

Approved
Approval ID

f108e431-f8d3-4442-8a60-bfc1d8a7bafc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 14, 2021

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ethacrynic sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-297
Application NumberANDA204634
Product Classification
M
Marketing Category
C73584
G
Generic Name
ethacrynic sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 15, 2014
FDA Product Classification

INGREDIENTS (2)

ETHACRYNATE SODIUMActive
Quantity: 50 mg in 50 mL
Code: K41MYV7MPM
Classification: ACTIM
MANNITOLInactive
Quantity: 62.5 mg in 50 mL
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ethacrynic Sodium - FDA Drug Approval Details